Katherine,
Since it is so small, and you have been working hard, you should take a little rest, to recharge your batteries. There really is no hurry on this one.
- - - - - -
Meanwhile, being vigilant about keeping the radiation option in reasonable perspective, I did look up the article. Here is the link:
http://www.ncbi.nlm.nih.gov/pubmed/17704364There are some relevant quotes from the abstract:
"Review of these 20 cases revealed 10 de novo secondary tumors, of which eight were malignant, with six being malignant gliomas."So it is actually 8 malignant tumors, not 20, though there is report of malignant nerve sheath growth in some of the NF2 patients as well.
"The majority of the cases (14 of 20) involved AN, with most being in patients with neurofibromatosis-2 (NF2; 8 of 14), reflecting the large numbers and long-term use of radiotherapy for AN."The 20 includes 8 NF2 cases, 6 regular ANs, and 6 other cases. Of all these, 8 showed new malignant tumors; which ones is not specified. The NF2 patients would have undergone radiation treatment multiple times, for multiple tumors.
"The exact carcinogenic risk after radiotherapy is unknown but likely extremely low."Well under 1 in 1000, certainly.
"However, the risk is not zero and requires discussion with the patient, with specific consideration in young patients and those with a cancer predisposition."Can't argue with that; the discussion should include an accurate synopsis of the actual number of AN-related malignant tumors, and the actual risk level. Nothing is perfect. I don't think a risk below 0.1% is worth considering; it is comparable to the fatality rate of AN surgery.
Steve